Palaparthi Sairam, Jagannath Byalal Raghavendrarao, Shastri Ramkinkar, Jayanthi Kishore, Rao Nitin Krishna, Vyas Suman, Inguava Savitri, Shekhada Nikunj, Siva Sai Kiran Krishnamurthy Venkata Satya, Mannam Gopichand
Department of Cardiothoracic Surgery, Star Hospitals, Hyderabad, Telangana, India.
Department of Anesthesiology, Star Hospitals, Hyderabad, Telangana, India.
Ann Pediatr Cardiol. 2022 May-Jun;15(3):229-237. doi: 10.4103/apc.apc_104_21. Epub 2022 Nov 16.
Surgical correction of total anomalous pulmonary venous connection (TAPVC) remains associated with significant mortality despite advances in intra-operative and postoperative management. We retrospectively analyzed 492 consecutive TAPVC patients with biventricular physiology, who were operated at our centre, with regard to predictors of mortality, morbidity, and intermediate-term outcomes.
A total of 492 TAPVC patients with biventricular physiology were operated at our centre from August 2009 to November 2019. Their medical records were reviewed and were followed up during March-April 2020 for any symptoms of cardiac disease.
Of 492, 302 (61.38%) were healthy at follow-up, 29 (5.89%) had postoperative mortality, 23 (4.67%) had mortality during the follow-up period, and 138 (28.05%) were lost to follow up. Age <1 month and weight <2.5 kg were associated with higher mortality with odds ratios (OR) of 6.37 and 5.56, respectively. There was no difference in mortality in different types of TAPVC. Obstructed TAPVC was associated with higher mortality with OR of 3.05. Acute kidney injury requiring peritoneal dialysis and sepsis were associated with higher mortality with ORs of 10.17 and 3.29, respectively. All follow-up mortality occurred in <1 year from the index operation. Anastomotic gradients were significantly higher in patients who died.
Although peri-operative TAPVC mortality has reduced, mortality on follow-up continues to occur and is partly due to the obstruction of pulmonary venous pathway. Meticulous follow-up holds the key in further reducing the mortality. Larger studies are needed for the identification of risk factors for pulmonary venous obstruction and its preventive strategies.
尽管术中及术后管理取得了进展,但完全性肺静脉异位连接(TAPVC)的手术矫正仍与显著的死亡率相关。我们回顾性分析了在我们中心接受手术的492例具有双心室生理功能的连续性TAPVC患者的死亡率、发病率及中期结局的预测因素。
2009年8月至2019年11月,我们中心共对492例具有双心室生理功能的TAPVC患者进行了手术。回顾了他们的病历,并在2020年3月至4月期间对任何心脏病症状进行了随访。
492例患者中,302例(61.38%)在随访时健康,29例(5.89%)术后死亡,23例(4.67%)在随访期间死亡,138例(28.05%)失访。年龄<1个月和体重<2.5 kg与较高的死亡率相关,比值比(OR)分别为6.37和5.56。不同类型的TAPVC死亡率无差异。梗阻性TAPVC与较高的死亡率相关,OR为3.05。需要腹膜透析的急性肾损伤和脓毒症与较高的死亡率相关,OR分别为10.17和3.29。所有随访死亡均发生在首次手术<1年内。死亡患者的吻合口梯度显著更高。
尽管围手术期TAPVC死亡率有所降低,但随访期间仍有死亡发生,部分原因是肺静脉通路梗阻。细致的随访是进一步降低死亡率的关键。需要更大规模的研究来确定肺静脉梗阻的危险因素及其预防策略。